INCRETIN-BASED THERAPY AND CANCER: ARE THEY ENEMIES OR ALLIES? | ||||
| Bulletin of Pharmaceutical Sciences Assiut University | ||||
| Volume 47, Issue 2, December 2024, Page 1273-1295 PDF (916.51 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/bfsa.2024.308996.2222 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Sandy R. Botros; Asmaa Matouk; Gehan Heeba  
| ||||
| Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, El-Minia, Egypt | ||||
| Abstract | ||||
| The link between cancer and diabetes is established but not fully understood. Incretin-based therapies have been increasingly used in the past decade for management of type 2 diabetes mellitus (T2DM). A link between incretin pathway and cancer has been supposed but a debate in the scientific committee is rising whether incretin-based therapies have beneficial or harmful effects on patients with malignant diseases or at risk of malignancy. This review summarizes the published preclinical and clinical research discussing incretin-based therapies and cancer. Except for pancreatic cancer, thyroid cancer, and cholangiocarcinoma, the published data agree that incretin-based therapies have either a beneficial or zero effect on risk of malignancy. Regarding pancreatic cancer, there are case reports of pancreatic cancer after receiving incretin-based drug therapy but the lag time for tumorigenesis is questionable. Till date, meta-analyses agreed that no increased incidence of pancreatic cancer was observed among users of incretin-based therapies. Whether incretin-based therapies increase the risk of thyroid cancer is controversial therefore it is advisable to avoid prescribing glucagon-like peptide-1 receptor agonists (GLP-1RAs) for patients with high risk for thyroid cancer. Despite the numerous studies published about incretins and cancer, it is still a rich area for further research. | ||||
| Keywords | ||||
| Cancer; Incretin; Glucagon-like peptide-1; Dipeptidyl peptidase 4 inhibitors; Type 2 diabetes mellitus | ||||
|
Statistics Article View: 326 PDF Download: 248 |
||||
